Who owns Apogee Therapeutics, Inc. (APGE)? Elite investor 13F holders
4 tracked elite investors reported holding Apogee Therapeutics, Inc as of 2026-06-30, including D.E. Shaw, Renaissance Technologies LLC, GMO, GAMCO. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
4 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| D.E. Shaw | APOGEE THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 32662995.00 USD | 246086.000000 | Shares | add | Original filing |
| Renaissance Technologies LLC | APOGEE THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 19484764.00 USD | 146800.000000 | Shares | buy | Original filing |
| GMO | APOGEE THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 18236438.00 USD | 137395.000000 | Shares | buy | Original filing |
| GAMCO | APOGEE THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-12 00:00:00 | 1128205.00 USD | 8500.000000 | Shares | buy | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.